Alkermes plc Cash Conversion Cycle 2011-2026 | ALKS

Annual Cash Conversion Cycle Alkermes plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
299	276	262	302	253	224	179	205	183	140	93	129	133	151	123

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
302	93	197

Quarterly Cash Conversion Cycle Alkermes plc

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
278	347	-	265	235	273	-	236	227	321	-	166	141	276	-	280	254	292	-	263	263	222	-	194	178	211	-	224	194	197	-	194	184	101	-	96.8	89.3	101	-	92.9	93.7	86.9	-	86.4	90.1	100	-	87.6	88.3	70.9	74.5	87.5	38.3	-	66.9	14	7.83	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
347	7.83	168

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	46.6	$ 330.34	3.6 %	$ 43.3 B	USA
CollPlant Biotechnologies Ltd. CLGN	130	$ 0.44	-16.64 %	$ 5.04 M	Israel
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Catalyst Pharmaceuticals CPRX	120	$ 24.98	1.17 %	$ 3.05 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Cardiff Oncology CRDF	294	$ 1.58	-	$ 106 M	USA
Curis CRIS	103	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	-4.27 K	$ 37.7	1.26 %	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 49.15	-0.73 %	$ 4.42 B	Schweiz
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
CytomX Therapeutics CTMX	12.2	$ 4.4	-3.51 %	$ 607 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Cue Biopharma CUE	43.1	$ 0.18	-1.61 %	$ 17.1 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Aquestive Therapeutics AQST	-172	$ 4.09	-0.97 %	$ 437 M	USA
Cyclerion Therapeutics CYCN	120	$ 4.15	-32.52 %	$ 10.4 M	USA
Daré Bioscience DARE	-1.64 K	$ 1.81	4.02 %	$ 20.2 M	USA
DBV Technologies S.A. DBVT	71.3	$ 20.36	-3.32 %	$ 2.84 B	France
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.22	2.37 %	$ 225 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Denali Therapeutics DNLI	1.89	$ 19.38	-6.15 %	$ 3.19 B	USA
Dyadic International DYAI	-26.6	$ 0.87	-2.8 %	$ 31.5 M	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-3.74 K	$ 31.37	1.0 %	$ 2.08 B	USA